Overview

LiDCO's strategy is to apply a multi-disciplinary combination of physiological expertise, materials technology, computing technology and software to monitor and display the relationship between linked physiological variables at the appropriate frequency and at the point of care. The transformation of raw physiological data into useable information has been a key objective throughout the development of the Company's products.

The Group researches, develops, manufactures and sells innovative medical devices primarily for critical care and cardiovascular risk hospital patients who require real-time cardiovascular monitoring while undergoing major surgery, intensive care or cardiology procedures. The Group's current principal products are a patent protected sensor product (the LiDCO System) and a patent protected monitoring product (the PulseCO System), which when used together provide a range of data concerning the performance of a patient's heart and blood circulation. The Group's products are designed for point-of-care use and are minimally invasive, portable and easy to use at a patient's bedside.

The Group's principal customers are hospitals and, to date, a number of sales have been made to major teaching hospitals in the United Kingdom, continental Europe, the Far East and the USA. The Group has different distribution strategies for each of these territories. In the UK and USA, the Group has established sales and marketing presence through a direct sales force. In continental Europe, Japan and the Far East the Company has established distribution through independent agents.